Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects

Authors


  • Clinical trial registration: ClinicalTrials.gov number NCT00413608

Jean-Sébastien Hulot, Service de Pharmacologie, Unité de Pharmacogénétique, Hôpital Pitié-Salpêtrière, 47 Bvd de l’hôpital, 75013 Paris, France.
Tel.: +33 142161661; fax: +33 142161688. E-mail: jean-sebastien.hulot@psl.aphp.fr

Ancillary